Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuro-endocrine Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 0 results

Early research (Phase 1)Study completedNCT02134639
What this trial is testing

PET-CT Imaging of Neuro-endocrine Tumors and Preliminary Clinical Evaluation

Who this might be right for
Neuroendocrine Tumors
University Hospital, Bordeaux 20
Not applicableEnded earlyNCT04452396
What this trial is testing

CGM (Continuous Glucose Monitoring) Use in Diagnosis of Spontaneous and Reactive Hypoglycaemia

Who this might be right for
Hypoglycemia, ReactiveHypoglycaemia NightHypoglycemia Non-Diabetic+7 more
Barts & The London NHS Trust 7
Post-approval studies (Phase 4)Ended earlyNCT04140409
What this trial is testing

Sandostatin (Octreotide LAR) May Lead to Clinical Improvement Through Receptor Occupation Optimisation

Who this might be right for
Neuroendocrine TumorsCarcinoid Syndrome
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 10